Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
7.61M | 7.83M | 3.78M | 2.08M | 240.20K | 553.77K | Gross Profit |
6.45M | 7.74M | 3.65M | 1.89M | 72.15K | 374.87K | EBIT |
2.96M | 3.14M | 670.22K | 630.40K | 38.44M | -2.59M | EBITDA |
2.53M | 3.14M | 841.03K | -1.19M | -3.68M | -2.84M | Net Income Common Stockholders |
2.04M | 3.04M | 840.18K | -2.83M | -87.57M | -3.45M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
14.16M | 16.93M | 11.37M | 9.12M | 10.84M | 9.56M | Total Assets |
14.61M | 62.59M | 53.11M | 51.67M | 11.93M | 10.45M | Total Debt |
0.00 | 191.23K | 235.03K | 229.30K | 333.13K | 181.51K | Net Debt |
-7.09M | -6.19M | -3.42M | -2.21M | -3.28M | -3.27M | Total Liabilities |
1.87M | 1.01M | 833.21K | 974.57K | 1.05M | 468.08K | Stockholders Equity |
12.74M | 61.58M | 52.28M | 50.69M | 10.88M | 9.98M |
Cash Flow | Free Cash Flow | ||||
3.29M | -498.60K | 671.42K | -3.56M | -3.87M | -4.49M | Operating Cash Flow |
3.09M | 1.36M | 687.12K | -3.53M | -3.79M | -4.42M | Investing Cash Flow |
-1.67M | -3.80M | -349.41K | 2.05M | -1.16M | 717.72K | Financing Cash Flow |
2.94M | 5.29M | 251.49K | 718.10K | 4.97M | 194.13K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | C$296.42M | 96.71 | 3.26% | ― | 9.80% | -17.83% | |
70 Outperform | C$3.11B | 160.94 | 1.00% | 0.76% | 0.80% | 137.87% | |
61 Neutral | $4.72B | 17.64 | -3.07% | 10.89% | 5.99% | -21.86% | |
58 Neutral | $305.73M | ― | -2.79% | ― | 19.37% | 31.57% | |
56 Neutral | C$5.51B | 247.32 | 1.33% | 0.89% | 1.62% | -232.31% | |
36 Underperform | $505.42K | ― | -362.48% | ― | ― | 87.27% |
Orogen Royalties Inc. announced its annual equity compensation grant, which includes 324,000 Restricted Share Units, 62,000 Deferred Share Units, and 977,000 incentive Stock Options allocated to its directors, officers, employees, and consultants. This decision, made under their Omnibus Equity Incentive Compensation Plan, reflects Orogen’s strategic approach to incentivize its workforce while securing regulatory acceptance from the TSX Venture Exchange.
Orogen Royalties announced a new purchase and sale agreement with K2 Gold Corporation, allowing K2 to acquire a 100% interest in the Si2 gold project in Nevada, USA. This agreement replaces a previous option agreement and grants Orogen a 2% net smelter return royalty, demonstrating potential for gold-bearing systems comparable to other large projects in the region and allowing K2 to advance exploration effectively despite market challenges.
Orogen Royalties Inc. has been selected to participate in BHP’s 2025 Xplor program, which will allow the company to enter new areas for generative exploration with the support of BHP’s expertise and networks. This opportunity provides Orogen with a non-dilutive grant and in-kind services, enabling them to develop geological concepts and design exploration programs. This collaboration is expected to enhance Orogen’s exploration capabilities and expedite their operations, highlighting their strengths in concept-based and data-driven exploration.
Orogen Royalties reported a strong quarter with a significant rise in royalty revenue, driven by higher gold prices. Despite a net comprehensive loss due to a non-cash write-down, the company saw a substantial increase in cash flow from operations. The firm remains optimistic about its portfolio of unique projects and future revenue potential.